Mark W. Kroll

Mark W. Kroll (board member) discloses dealings in 2 companies, chiefly Haemonetics Corp and Axon Enterprise, Inc. Between 12 May 2021 and 24 July 2026, the trades on record add up to 15 filings.

On the open market, the record shows 1 purchase worth €86k and 4 sales worth €1.3M. Taken together, the sales exceed the purchases by €1.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 9 share grants and 1 option exercise.

The record was last updated on 28 July 2026 with a share grant in Haemonetics Corp. The clock since the last published purchase (12 November 2025) now reads 340 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.